Search





Search





Markets
/
Stocks
/
calc
/

CalciMedica Inc

CALC

Add to Watchlist

1.000USD

+0.160+19.05%

Close 07-31 16:00（ET）Quotes delayed by 15 min

30.74MMarket Cap

LossP/E TTM

CalciMedica Inc

1.000

+0.160+19.05%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

CALC Cash Flow Statement

You can access the annual and quarterly cash flow statements of CalciMedica Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

Operating cash flows (indirect method)

Cash flow from continuing operating activities

0.45%-4.86M

2.41%-4.85M

-2.38%-4.78M

1.80%-6.67M

-3.46%-4.88M

-37.65%-4.97M

-2.10%-4.67M

44.29%-6.79M

11.95%-4.71M

28.80%-3.61M

36.01%-4.57M

-194.56%-12.19M

17.92%-5.36M

43.35%-5.07M

-29.87%-7.14M

46.81%-4.14M

29.58%-6.52M

8.35%-8.96M

-2.61%-5.50M

---7.78M

---9.26M

---9.77M

---5.36M

Net income from continuing operations

198.69%4.98M

-152.70%-10.76M

-38.91%-7.80M

-50.63%-5.96M

-3978.46%-5.04M

-2.70%-4.26M

-21.63%-5.62M

37.28%-3.95M

100.67%130.00K

44.00%-4.15M

52.92%-4.62M

23.50%-6.30M

-90.05%-19.29M

14.66%-7.40M

-22.82%-9.81M

-6.91%-8.24M

11.35%-10.15M

5.21%-8.68M

-69.40%-7.99M

---7.71M

---11.45M

---9.15M

---4.72M

Operating gains losses

-53.33%7.00K

-64.29%5.00K

-20.00%12.00K

0.00%14.00K

0.00%15.00K

-26.32%14.00K

25.00%15.00K

0.00%14.00K

15.38%15.00K

-93.45%19.00K

-99.14%12.00K

-88.80%14.00K

-89.34%13.00K

113.24%290.00K

929.41%1.40M

-3.10%125.00K

3.39%122.00K

22.52%136.00K

41.67%136.00K

--129.00K

--118.00K

--111.00K

--96.00K

Other non-cash items

-101.75%-4.00K

67.24%-38.00K

20.72%-88.00K

49.08%-111.00K

-62.81%228.00K

-38.10%-116.00K

-1750.00%-111.00K

-311.32%-218.00K

467.59%613.00K

56.02%-84.00K

-100.00%-6.00K

-167.95%-53.00K

-95.24%108.00K

-1023.53%-191.00K

-142.86%-3.00K

188.89%78.00K

5570.00%2.27M

-194.44%-17.00K

--7.00K

--27.00K

--40.00K

--18.00K

--0.00

Change in working capital

-46.06%404.00K

-117.54%-80.00K

428.31%877.00K

-69.76%-1.39M

352.19%749.00K

-27.73%456.00K

137.73%166.00K

87.01%-820.00K

-105.07%-297.00K

29.04%631.00K

12.87%-440.00K

-393.58%-6.31M

2006.84%5.85M

125.71%489.00K

-155.19%-505.00K

239.52%2.15M

-134.19%-307.00K

-23.91%-1.90M

14.23%915.00K

---1.54M

--898.00K

---1.54M

--801.00K

-Change in prepaid expenses

-69.73%122.00K

-46.54%255.00K

-2.34%292.00K

11.35%-414.00K

175.05%403.00K

-5.92%477.00K

-68.26%299.00K

-132.91%-467.00K

-516.28%-537.00K

-8.15%507.00K

1782.14%942.00K

-26.59%1.42M

-72.32%129.00K

137.65%552.00K

-108.89%-56.00K

245.18%1.93M

-71.83%466.00K

44.19%-1.47M

1752.94%630.00K

--560.00K

--1.65M

---2.63M

--34.00K

-Change in other current liabilities

----

-211.19%-1.18M

-43.50%291.00K

137.93%187.00K

-19.72%-1.18M

4.52%1.06M

10.04%515.00K

---493.00K

---989.00K

--1.02M

--468.00K

Cash from non-recurring investing activities

Cash from operating activities

0.45%-4.86M

2.41%-4.85M

-2.38%-4.78M

1.80%-6.67M

-3.46%-4.88M

-37.65%-4.97M

-2.10%-4.67M

44.29%-6.79M

11.95%-4.71M

28.80%-3.61M

36.01%-4.57M

-194.56%-12.19M

17.92%-5.36M

43.35%-5.07M

-29.87%-7.14M

46.81%-4.14M

29.58%-6.52M

8.35%-8.96M

-2.61%-5.50M

---7.78M

---9.26M

---9.77M

---5.36M

Investing cash flow

Net cash from continuing investing activities

-100.00%0.00

200.00%6.00K

33.33%8.00K

--5.00K

--9.00K

--2.00K

--6.00K

----

100.00%0.00

-100.00%0.00

-54.91%78.00K

--0.00

-8850.00%-350.00K

-69.44%55.00K

2.98%173.00K

-100.00%0.00

-99.52%4.00K

318.60%180.00K

--168.00K

--136.00K

--826.00K

--43.00K

Capital expenditures

-100.00%0.00

200.00%6.00K

33.33%8.00K

--5.00K

--9.00K

--2.00K

--6.00K

----

--0.00

-100.00%0.00

-54.91%78.00K

--0.00

-100.00%0.00

-25.00%135.00K

2.98%173.00K

-100.00%0.00

-99.52%4.00K

318.60%180.00K

--168.00K

--136.00K

--826.00K

--43.00K

Net cash flow from disposal of fixed assets

-100.00%0.00

200.00%6.00K

33.33%8.00K

--5.00K

--9.00K

--2.00K

--6.00K

----

100.00%0.00

-100.00%0.00

-54.91%78.00K

--0.00

-8850.00%-350.00K

-69.44%55.00K

2.98%173.00K

-100.00%0.00

-99.52%4.00K

318.60%180.00K

--168.00K

--136.00K

--826.00K

--43.00K

Net cash flow from investment products

221.56%1.50M

238.51%7.15M

-59.79%3.52M

-97.27%139.00K

90.58%-1.23M

-92.94%-5.17M

397.62%8.75M

-48.12%5.10M

-375.85%-13.10M

-122.48%-2.68M

-183.72%-2.94M

-2.81%9.83M

46.47%4.75M

10.38%11.91M

-61.98%3.51M

113.87%10.11M

123.98%3.24M

117.51%10.79M

--9.24M

--4.73M

---13.52M

---61.64M

--0.00

Net cash flow from other investing activities

--0.00

----

--0.00

---221.00K

---1.72M

----

Cash from non-current investing activities

Net cash flow from investing activities

220.68%1.50M

238.34%7.15M

-59.85%3.51M

-97.37%134.00K

90.51%-1.24M

-93.01%-5.17M

397.42%8.75M

-47.70%5.10M

-375.85%-13.10M

-121.84%-2.68M

-185.05%-2.94M

0.33%9.75M

212.50%4.75M

13.67%12.26M

-61.84%3.46M

113.11%9.72M

111.13%1.52M

117.27%10.79M

21172.09%9.06M

--4.56M

---13.66M

---62.46M

---43.00K

Financing cash flow

Cash flow from continuous financing activities

-100.00%0.00

-57.92%3.75M

5012.50%818.00K

-1357.14%-102.00K

-43.59%10.74M

4998.29%8.92M

-77.78%16.00K

99.76%-7.00K

-19.02%19.04M

430.19%175.00K

523.53%72.00K

-4047.83%-2.86M

--23.52M

-165.43%-53.00K

-162.96%-17.00K

-113.94%-69.00K

-100.00%0.00

-99.24%81.00K

-99.97%27.00K

--495.00K

--92.00K

--10.68M

--82.83M

Net cash flow from debt Issuance/repayment

-100.00%0.00

--0.00

---102.00K

--9.77M

----

Net cash flow from common stock issuance/repurchase

-100.00%0.00

-57.92%3.75M

--793.00K

-100.00%0.00

-94.87%976.00K

5027.59%8.92M

-100.00%0.00

--49.00K

84.17%19.04M

--174.00K

--72.00K

--0.00

--10.34M

----

-100.00%0.00

----

--12.55M

--83.70M

Net cash flow from preferred stock issuance/repurchase

----

--0.00

----

--0.00

Proceeds from stock option exercised by employees

----

--0.00

56.25%25.00K

----

--0.00

--16.00K

--4.00K

----

--0.00

----

-100.00%0.00

--81.00K

-50.00%27.00K

--495.00K

--92.00K

--0.00

--54.00K

Net cash flow from other financing activities

--0.00

----

-100.00%0.00

--0.00

97.90%-60.00K

-100.00%0.00

101.89%1.00K

100.00%0.00

-4047.83%-2.86M

--13.18M

---53.00K

---17.00K

---69.00K

----

100.00%0.00

--0.00

---1.87M

---925.00K

Net cash from non-recurrent financing activities

Net cash from financing activities

-100.00%0.00

-57.92%3.75M

5012.50%818.00K

-1357.14%-102.00K

-43.59%10.74M

4998.29%8.92M

-77.78%16.00K

99.76%-7.00K

-19.02%19.04M

430.19%175.00K

523.53%72.00K

-4047.83%-2.86M

--23.52M

-165.43%-53.00K

-162.96%-17.00K

-113.94%-69.00K

-100.00%0.00

-99.24%81.00K

-99.97%27.00K

--495.00K

--92.00K

--10.68M

--82.83M

Net cash flow

Beginning cash balance

45.18%11.52M

-40.23%5.47M

17.05%5.92M

85.88%12.56M

43.49%7.94M

-21.40%9.15M

-73.51%5.06M

-72.30%6.75M

274.66%5.53M

14.49%11.64M

37.57%19.08M

191.70%24.39M

-88.96%1.48M

-11.19%10.17M

76.40%13.87M

-21.05%8.36M

-60.01%13.36M

-87.94%11.45M

-55.17%7.86M

--10.59M

--33.42M

--94.97M

--17.54M

Current period cash flow changes

-172.62%-3.36M

597.12%6.05M

-110.94%-448.00K

-290.70%-6.64M

277.22%4.62M

80.09%-1.22M

155.05%4.10M

67.96%-1.70M

-94.65%1.23M

-185.70%-6.11M

-100.97%-7.44M

-196.19%-5.30M

557.83%22.91M

273.12%7.13M

-203.18%-3.70M

302.28%5.51M

78.08%-5.00M

103.11%1.91M

-95.37%3.59M

---2.73M

---22.83M

---61.55M

--77.43M

Ending cash balance

-34.98%8.16M

45.18%11.52M

-40.23%5.47M

17.05%5.92M

85.88%12.56M

43.49%7.94M

-21.40%9.15M

-73.51%5.06M

-72.30%6.75M

-68.04%5.53M

14.49%11.64M

37.57%19.08M

191.70%24.39M

29.48%17.30M

-11.19%10.17M

76.40%13.87M

-21.05%8.36M

-60.01%13.36M

-87.94%11.45M

--7.86M

--10.59M

--33.42M

--94.97M

Free cash flow

0.63%-4.86M

2.33%-4.86M

-2.42%-4.79M

1.72%-6.67M

-3.65%-4.89M

-37.71%-4.97M

-2.23%-4.67M

44.65%-6.79M

11.95%-4.71M

28.80%-3.61M

37.19%-4.57M

-184.55%-12.27M

17.92%-5.36M

43.38%-5.07M

-28.13%-7.28M

45.75%-4.31M

30.60%-6.52M

15.46%-8.96M

-5.13%-5.68M

---7.95M

---9.40M

---10.60M

---5.40M

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did CalciMedica Inc Generate?



CalciMedica Inc generated -21.18M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did CalciMedica Inc's Operating Cash Flow Change Year Over Year?



CalciMedica Inc's operating cash flow increased by -0.15% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does CalciMedica Inc Spend on Capital Expenditures?



CalciMedica Inc spent 28.00K on capital expenditures in the most recent quarter。

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has CalciMedica Inc's Financing Cash Flow Changed?



CalciMedica Inc used 15.21M in financing activities in the latest quarter.

What is free cash flow and why does it matter for CALC?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was CalciMedica Inc’s free cash flow in the latest quarter?



Free cash flow was -21.21M reflecting a -0.25% change from the previous year.